Latest News about VTRS
Recent news which mentions VTRS
3 Stocks With Dividends of 3% or More to Buy on the Dip
November 14, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
From Benzinga
Want to Collect a High Dividend Every Month? Buy These 3 Stocks
November 10, 2022
From Motley Fool
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
From Benzinga
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
November 08, 2022
From Benzinga
From Benzinga
Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session
November 07, 2022
From Benzinga
Why Viatris Stock Is Jumping Today
November 07, 2022
From Motley Fool
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge
November 07, 2022
From Benzinga
IAA Stock Moves as Ritchie Bros Acquires Company in $7.3 Billion Deal
November 07, 2022
From InvestorPlace
Viatris (VTRS) Stock Pops 17% on Acquisition News
November 07, 2022
From InvestorPlace
What Does Sunshine Biopharma's Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market?
November 07, 2022
From Benzinga
Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much'
November 07, 2022
From Benzinga
Earnings Scheduled For November 7, 2022
November 07, 2022
From Benzinga
Viatris' Mylan Recalls One Lot Of Octreotide Acetate Injection Due To Glass Particulates
October 26, 2022
Tickers
VTRS
From Benzinga
3 Feel-Good Ways to Lose Lots of Money in the Bear Market
October 26, 2022
From Motley Fool
3 Healthcare Stocks That Are Too Cheap to Ignore
October 22, 2022
From Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
October 22, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
October 21, 2022
From Benzinga
Novartis Fails To Prevent Generic Competition For Its Blockbuster Multiple Sclerosis Drug
October 14, 2022
From Benzinga
21 dividend stocks yielding 5% or more of companies that will produce plenty of cash in 2023
October 04, 2022
From MarketWatch
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.